May Measurement Month 2017-19: an analysis of blood pressure screening results from Paraguay

Blood pressure Control Hypertension Screening Treatment

Journal

European heart journal supplements : journal of the European Society of Cardiology
ISSN: 1520-765X
Titre abrégé: Eur Heart J Suppl
Pays: England
ID NLM: 100886647

Informations de publication

Date de publication:
Sep 2022
Historique:
entrez: 13 10 2022
pubmed: 14 10 2022
medline: 14 10 2022
Statut: epublish

Résumé

The aim of this study was to highlight the importance of measuring blood pressure (BP) and to identify and reduce the BPs of those people who require intervention to lower their BP according to current guidelines. A total of 7782 individuals aged ≥18 years were recruited during the 3 years of the May Measurement Month (MMM) campaign (2017: 1196, 2018: 2285, 2019: 4301). Recruitment was through opportunistic sampling at a variety of screening sites distributed throughout the country. Each participant underwent a pre-specified questionnaire with questions on risk factors concluding with three BP measurements at 1 min intervals and measurement of weight and height. Hypertension was defined as a systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg or those receiving antihypertensive therapy. Of all 7782 participants, 3323 had hypertension (42.7%) of whom 61.8% were aware and 50.4% were not receiving antihypertensive medication. Of those treated (49.6%), 43.8% had controlled BP (<140/90 mmHg). Among all hypertensive patients (with and without medication), 21.7% had controlled BP. In relation to previous surveys carried out in the country, awareness of hypertension increased two-fold, with no change in the proportion of hypertensive patients on treatment and the proportion of hypertensive patients with controlled BP which remained low.

Identifiants

pubmed: 36225272
doi: 10.1093/eurheartjsupp/suac047
pii: suac047
pmc: PMC9547519
doi:

Types de publication

Journal Article

Langues

eng

Pagination

F34-F37

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.

Déclaration de conflit d'intérêts

Conflict of interest: None of the researchers who participated in the MMM have any conflict of interest.

Références

Lancet Glob Health. 2018 Jul;6(7):e736-e743
pubmed: 29778399
Eur Heart J. 2019 Jul 1;40(25):2006-2017
pubmed: 31041440
Hypertension. 2020 Aug;76(2):333-341
pubmed: 32419505
J Hum Hypertens. 1995 Nov;9(11):891-7
pubmed: 8583468

Auteurs

José Ortellado (J)

National Program for Cardiovascular Prevention of the Ministry of Public Health and Social Welfare, Asuncion, CP 1548, Paraguay.

María Paniagua (M)

National Program for Cardiovascular Prevention of the Ministry of Public Health and Social Welfare, Asuncion, CP 1548, Paraguay.

Wei Wang (W)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.

Thomas Beaney (T)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Department of Primary Care and Public Health, Imperial College London, St Dunstan's Road, London W6 8RP, UK.

Neil R Poulter (NR)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.

Graciela González (G)

National Program for Cardiovascular Prevention of the Ministry of Public Health and Social Welfare, Asuncion, CP 1548, Paraguay.

Manuel Castillo (M)

National Program for Cardiovascular Prevention of the Ministry of Public Health and Social Welfare, Asuncion, CP 1548, Paraguay.

Rocío Aparicio (R)

National Program for Cardiovascular Prevention of the Ministry of Public Health and Social Welfare, Asuncion, CP 1548, Paraguay.

Abdón Villamayor (A)

National Program for Cardiovascular Prevention of the Ministry of Public Health and Social Welfare, Asuncion, CP 1548, Paraguay.

Classifications MeSH